Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market

JERUSALEM and NEEDHAM, Massachusetts, August 18, 2010 /PRNewswire-FirstCall/ -- Oridion (SIX Swiss Exchange: ORIDN), creator of the Smart Capnography(TM) family of algorithm-based solutions (Integrated Pulmonary Index(TM), SARA(TM), and Smart Breath Detection Algorithm(TM)), announced the signing of a new agreement with IMI Co. Ltd., a leading distributor of medical equipment in Japan. This agreement provides Oridion with the opportunity to further expand into the Japanese market with its line of Microstream(R) capnography monitoring products.

IMI will bundle sales of Capnostream(R)20 Smart Capnography monitors including IPI* with their ventilators. This powerful combination will be offered as SafetySet(TM), an innovative solution to improve patient safety and make a clinical difference in patient care. IMI will begin selling the Capnostream(R)20 monitors and patented FilterLine(R) etCO2 sampling products immediately into the Critical Care environment and Home Care areas throughout Japan.

Mr. Kazumasa Tsumuga, President of IMI, said: "We are happy to join with Oridion to make available the best capnography technology to our hospital markets in Japan. We believe the collaboration between IMI and Oridion will help improve the safety for all the patient populations in all clinical settings in Japan."

Gerry Feldman, President of Oridion Capnography Inc., remarks, "We are honored to be working with IMI. The SafetySet package combining Capnostream capnography with ventilators sold by IMI is a pioneering strategy that will provide added safety for patients in hospitals throughout Japan. Oridion is committed to improving the standard of healthcare worldwide and will continue to offer new ways to improve patient safety and make a clinical difference in patient care."

*IPI helps caregivers manage complicated monitoring parameters with a single, simple number. The IPI utilizes real time measures and interactions of four parameters - exhaled carbon dioxide (etCO2), respiration rate, pulse rate, and oxygenation (SpO2) - to provide a single indexed value, enabling clinicians to instantly assess the patient's respiratory status.

SARA (Smart Alarm Respiratory Analysis) is an alarm management algorithm that, together with the Smart Breath Detection Algorithm, recognizes and reduces clinically insignificant alarms while accurately reflecting the patient's condition and preserving caregiver alarm vigilance.

About Oridion

Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

Certain statements made herein that are not historical are forward-looking. The words "estimate" "project" "intend" "expect" "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, our ability to maintain profits, the market demands for our Capnography products, our ability to focus our team on the Capnography business, changes in general economic and business conditions, inability to maintain market acceptance to the Company's products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for the Company's products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company's proprietary technology. The Company does not assure any obligation to update the forward-looking information contained in this press release.

    For further Oridion information please contact:
    Alan Adler, Chairman and Chief Executive Officer
    Walter Tabachnik, Chief Financial Officer
    Elena Gerberg, Investor Relations
    e-mail: [email protected]
    website: http://www.oridion.com
    phone: +972-2-589-9159
    address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel

SOURCE Oridion Systems Ltd.